1800-272-662
Shopping Cart 0
countryflagAU
Login

RHYTHM Biosciences Ltd

Healthcare AU RHY

0.21AUD
0.01(5.00%)

Last update at 2026-03-13T05:10:00Z

Day Range

0.200.22
LowHigh

52 Week Range

0.050.28
LowHigh

Fundamentals

  • Previous Close 0.20
  • Market Cap65.60M
  • Volume551328
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.39968M
  • Revenue TTM1.65M
  • Revenue Per Share TTM0.005
  • Gross Profit TTM 1.01M
  • Diluted EPS TTM-0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -3.82937M -8.54700M -8.21756M -8.79352M -6.61215M
Minority interest - - - - -
Net income -3.82937M -6.85700M -8.21756M -6.31618M -7.72105M
Selling general administrative 1.67M 1.41M 7.33M 5.33M 2.97M
Selling and marketing expenses 3.45M 1.59M 0.18M 0.56M 0.06M
Gross profit 2.97M -1.35700M -0.32673M -0.17238M -2.17580M
Reconciled depreciation - 0.20M 0.19M 0.10M 0.15M
Ebit -3.72966M -8.54376M -11.54167M -11.24589M -6.61175M
Ebitda -3.53278M -8.34510M -11.35229M -11.14441M -6.46510M
Depreciation and amortization 0.20M 0.20M 0.19M 0.10M 0.15M
Non operating income net other - - - - -
Operating income -3.53287M -6.70700M -11.54167M -11.24589M -6.61175M
Other operating expenses 6.72M 8.40M 11.54M 11.25M 7.73M
Interest expense 0.07M 0.00314M - 0.02M 0.00040M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.07M 0.05M 0.23M 0.02M 0.01M
Net interest income - 0.05M 0.23M 0.02M 0.01M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - -1.69000M -0.22827M -2.47734M 1.11M
Total revenue 3.19M 1.69M 0.23M 0.02M 0.01M
Total operating expenses 6.50M 5.35M 11.54M 11.25M 7.73M
Cost of revenue 0.22M 3.05M 0.56M 0.20M 2.19M
Total other income expense net -0.29650M -1.84000M 3.10M 2.45M -0.00040M
Discontinued operations - - - - -
Net income from continuing ops - -6.85676M -8.21756M -8.79352M -6.61215M
Net income applicable to common shares -3.82937M -6.85676M -8.21756M -8.79352M -6.61215M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 2.83M 1.52M 7.70M 8.44M 3.07M
Intangible assets 0.32M - 0.39M 0.43M 0.46M
Earning assets - - - - -
Other current assets 0.19M 0.09M 0.12M 0.09M 0.06M
Total liab 2.17M 0.65M 1.82M 1.07M 1.36M
Total stockholder equity 0.66M 0.87M 5.87M 7.37M 1.71M
Deferred long term liab - - - - -
Other current liab 0.52M 0.27M 0.35M 0.57M 0.74M
Common stock 37.75M 34.45M 31.55M 27.83M 15.98M
Capital stock - - 31.55M 27.83M 15.98M
Retained earnings -42.50354M -38.67417M -31.81741M -23.59986M -14.80633M
Other liab - - 0.06M 0.05M 0.02M
Good will 0.53M - - - -
Other assets - 0.00000M - - -
Cash 1.40M 0.71M 4.12M 7.55M 2.23M
Cash and equivalents - - - - 2.23M
Total current liabilities 2.16M 0.56M 1.77M 0.93M 1.34M
Current deferred revenue - - - - -
Net debt -0.28994M -0.54567M -4.03958M -7.38028M -2.22840M
Short term debt 1.11M 0.08M 0.08M 0.09M 0.00000M
Short long term debt - - - - -
Short long term debt total 1.11M 0.16M 0.08M 0.17M -
Other stockholder equity - - 6.14M 3.14M 0.53M
Property plant equipment - - 0.10M 0.24M 0.11M
Total current assets 1.81M 0.89M 7.12M 7.77M 2.49M
Long term investments - - - - -
Net tangible assets - - 5.48M 6.95M 1.24M
Short term investments 0.09M 0.04M 0.04M 0.04M 0.04M
Net receivables 0.06M 0.04M 0.07M 0.08M 0.16M
Long term debt - - - - -
Inventory 0.07M - 2.77M - -
Accounts payable 0.53M 0.21M 1.33M 0.28M 0.60M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 5.41M 5.09M 6.14M 3.14M 0.53M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.35M - - -0.00003M
Deferred long term asset charges - - - - -
Non current assets total 1.02M 0.63M 0.58M 0.67M 0.58M
Capital lease obligations - - 0.08M 0.17M -
Long term debt total - - 0.00000M 0.08M 0.00000M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -0.08228M -0.09912M -0.02701M -0.06827M
Change to liabilities - - 0.00000M -0.55232M 0.51M
Total cashflows from investing activities -0.58296M -0.08228M -0.09912M -0.02701M -0.06827M
Net borrowings - - -0.08553M -0.00766M -0.04244M
Total cash from financing activities 4.19M 2.80M 3.63M 11.85M 5.90M
Change to operating activities - - -0.07549M 0.07M 0.04M
Net income -3.82937M -6.85676M -8.21756M -6.31618M -6.61215M
Change in cash 0.69M -3.41468M -3.42624M 5.32M 0.43M
Begin period cash flow 0.71M 4.12M 7.55M 2.23M 1.80M
End period cash flow 1.40M 0.71M 4.12M 7.55M 2.23M
Total cash from operating activities -2.92129M -6.13717M -6.95761M -6.21471M -5.40249M
Issuance of capital stock - 3.02M 3.74M 12.32M 6.17M
Depreciation 0.20M 0.20M 0.19M 0.10M 0.15M
Other cashflows from investing activities -0.55975M - - - -
Dividends paid - - - - -
Change to inventory 0.01M 2.77M -2.76668M -2.76668M -2.76668M
Change to account receivables 0.38M 0.03M 0.91M 0.07M -0.04020M
Sale purchase of stock 3.50M -0.11792M -0.02422M -0.46785M -0.22512M
Other cashflows from financing activities 1.00M -0.09273M -0.08553M -0.00766M -0.04244M
Change to netincome - - 3.00M 2.61M 0.56M
Capital expenditures 0.02M 0.08M 0.10M 0.03M 0.07M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.36M 1.57M 3.32M 2.45M 1.18M
Stock based compensation 0.35M -1.04802M - - -
Other non cash items -0.00009M -1.04802M - 6.21M 6.47M
Free cash flow -2.94450M -6.21945M -0.09912M -6.24171M -0.06827M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RHY
RHYTHM Biosciences Ltd		 0.01 5.00% 0.21 - - 39.81 34.43 1660.55 -11.0908
SHL
Sonic Healthcare Ltd		 0.09 0.43% 21.20 19.10 15.48 1.01 1.22 1.52 8.99
IDX
Integral Diagnostics Ltd		 0.01 0.43% 2.32 57.75 15.80 1.12 1.30 1.89 12.08
HLS
Healius Ltd		 - -% 0.59 - 26.25 0.32 0.78 0.96 10.14
ACL
Australian Clinical Labs Ltd		 -0.02 0.97% 2.05 14.79 12.17 0.54 2.75 0.96 3.92

Reports Covered

Stock Research & News

View All

Profile

Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

RHYTHM Biosciences Ltd

Bio21 Institute, Parkville, VIC, Australia, 3010

Key Executives

Name Title Year Born
Mr. Otto Leslie-Steven Buttula AIMM, B.Ec., Grad. Dip., MAICD Exec. Chairman 1964
Mr. Glenn Gilbert MD, CEO & Director NA
Dr. Trevor John Lockett Ph.D. Technical Director, Chair of the Clinical Advisory Board & Exec. Director NA
Mr. Paul Smith Chief Financial Officer & Joint Company Sec. NA
Ms. Andrea Steele LLB B Com LLM Gen. Counsel & Company Sec. NA
Ms. Elena Deak Chief Commercial Officer NA
Mr. Otto Leslie-Steven Buttula AIMM, B.Ec., Grad. Dip., MAICD Executive Chairman 1964
Mr. Guy Carisbrooke Financial Controller NA
Ms. Andrea Steele LLB B Com LLM General Counsel & Joint Company Secretary NA
Mr. James Stephen Barrie CPA Joint Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.